IBPM002BZ (Inbiopro Solutions)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIBPM002BZ (Inbiopro Solutions)
Drug Alias NameIBPM002BZ (biosimilar) - Inbiopro SolutionsIBPM-002BZ
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsSmall Cell Lung CarcinomaColorectal NeoplasmsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesInbiopro Solutions
China Registration ClassN/A

Develop Information

Active CompaniesInbiopro Solutions
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaColorectal NeoplasmsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A